๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest

Search Results

Found 125 results for "ehr" across articles, medicines, trials, companies and the glossary

AI Will Not Rescue Ireland's Over-Budget Health IT Projects. Pharma-Grade Governance Might.
Industry
AI Will Not Rescue Ireland's Over-Budget Health IT Projects. Pharma-Grade Governance Might.
Ireland is entering a 1.5 to 2 billion euro National Electronic Health Record programme with a poor record on large health IT projects. PPARS and the 2021 cyberattack were governance failures, not technology failures, and AI project tools inherit the optimism they are fed. This analysis argues that the discipline the HSE needs already exists in Irish pharma and MedTech under GAMP 5 and the FDA's Computer Software Assurance guidance.
23 hrs ago
Ireland's Eight-Year Citizenship Rule: A Talent-Retention Problem for Pharma, Biotech and MedTech
Pharmaceutical
Ireland's Eight-Year Citizenship Rule: A Talent-Retention Problem for Pharma, Biotech and MedTech
Ireland built a life-science powerhouse by being the easiest place in Europe for global talent to land and stay. The proposed move from five to eight years for citizenship changes the terms on which the sector's skilled workforce agreed to come here. This analysis looks at what it means for engineers and scientists on Critical Skills permits, for the companies that depend on them, and what a fairer Bill would look like.
3 days ago
From Pilots to Infrastructure: How AI is Becoming the Core Operating System for Biopharma R&D in 2026
MedTech
From Pilots to Infrastructure: How AI is Becoming the Core Operating System for Biopharma R&D in 2026
Artificial intelligence has evolved from sandbox pilot projects to become the default operating system driving drug discovery, clinical trials, and sterile manufacturing.
29 Jun 2026
The 2026 Obesity Power Rankings: Which Pharma Giants Can Break the Lilly-Novo Duopoly?
Clinical Trials
The 2026 Obesity Power Rankings: Which Pharma Giants Can Break the Lilly-Novo Duopoly?
With the obesity market projected to exceed $130 billion by 2034, we analyze the top 10 pharmaceutical companies vying for dominance. Explore our comprehensive Power Rankings assessing pipeline depth, clinical differentiation, and commercial infrastructure.
25 Jun 2026
The Innovation Exodus: Why Europe Must Rethink Medicine Pricing or Risk Losing Life Science Investments
Pharmaceutical
The Innovation Exodus: Why Europe Must Rethink Medicine Pricing or Risk Losing Life Science Investments
An in-depth analysis of the warnings from pharmaceutical lobby chief Stefan Oelrich regarding European cost-cutting reforms, global pricing shifts, and the threat to clinical research and manufacturing.
23 Jun 2026
Europe's United Front: How the Beneluxa Initiative is Defending the Pharma Framework Against US Pricing Pressure
Industry
Europe's United Front: How the Beneluxa Initiative is Defending the Pharma Framework Against US Pricing Pressure
With the US pushing for individual drug pricing deals and Germany slashing healthcare spending, the Beneluxa Initiative represents five European nations calling for a unified, coordinated approach to protect Europe's pharmaceutical innovation and access to medicines in 2026.
14 Jun 2026
From Generative to Agentic: How Multi-Agent AI Workflows Are Automating Clinical Trials in Ireland
MedTech
From Generative to Agentic: How Multi-Agent AI Workflows Are Automating Clinical Trials in Ireland
An in-depth analysis of the shift from passive generative AI to active agentic AI in clinical research. We explore how Irish clinical trial teams use multi-agent workflows to automate administrative burdens, GxP validation via local frameworks like Ollama, and how Priya LifePDF ensures document privacy.
10 Jun 2026
How the Iran Conflict Is Disrupting Irelandโ€™s Pharmaceutical Industry and Why It Matters Globally.
Pharmaceutical
How the Iran Conflict Is Disrupting Irelandโ€™s Pharmaceutical Industry and Why It Matters Globally.
Middle East air route disruptions are raising costs and delaying Irelandโ€™s pharma exports, impacting global medicine supply chains.
23 Mar 2026